Neurotropin Research Study

The National Institute of Nursing Research is conducting a study on the use of Neurotropin to treat pain associated with complex regional pain syndromes I and II (RSD and Causalgia). Neurotropin is a medication that is used currently in Japan to treat RSD and other painful conditions.

Subjects are now being recruited for this outpatient, double blind, placebo-controlled crossover study. For the initial trial of this drug in the United States, individuals who have been diagnosed within one year with CRPS Type I or II in only one limb can be referred by their physician. Also, an option has been approved for those patients who complete the trial and request an additional month on the agent placebo or active drug that resulted in apparent improvement.

To participate in the trial, contact:

Patient Recruitment and Public Liaison
Office Building 61
10 Cloister Court
Bethesda, Maryland 20892-4754

Toll Free: 1-800-411-1222
TTY: 301-594-9774 (local), 1-800-411-1010 (toll free)
Fax: 301-480-9793
Email:prpl@mail.cc.nih.gov

A detailed description of the study and information regarding the admission criteria are available on the Internet. The simplest way of looking at this web page is to search for "Neurotropin" at the website www.clinicaltrials.gov.

Source

Added September 2008